Research / XYL / Fundamental state Inspectable configuration
State dimensions Filing 0001524472-15-000023 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.33% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.19% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-6.33% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
52.88% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
38.91% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
13.30% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.55% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.33% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Mar 31, 2019 8/8 normalized Level 3 Jun 30, 2019 7/7 normalized Level 3 Sep 30, 2019 8/8 normalized Level 3 Dec 31, 2019 8/8 normalized Level 3 Mar 31, 2020 8/8 normalized Level 3 Jun 30, 2020 8/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Dec 31, 2020 8/8 normalized Level 3 Mar 31, 2021 8/8 normalized Level 3 Jun 30, 2021 8/8 normalized Level 3 Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 2.17%
Current 2.33%
Delta 0.15% Cash Generation Increased
Previous 9.13%
Current 15.19%
Delta 6.06% Growth Increased
Previous -8.46%
Current -6.33%
Delta 2.12% Inventory Pressure Decreased
Previous 54.13%
Current 52.88%
Delta -1.25% Margin Increased
Previous 37.83%
Current 38.91%
Delta 1.09% Profitability Increased
Previous 11.30%
Current 13.30%
Delta 2.00% R And D Intensity Decreased
Previous 2.72%
Current 2.55%
Delta -0.17% Sbc Intensity Decreased
Previous 0.43%
Current 0.33%
Delta -0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.